Contract 75F40122C00116
Regents Of The University Of California, San Francisco, The · Department Of Health And Human Services · August 21, 2024
Regents Of The University Of California, San Francisco, The was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on August 21, 2024 for $919,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in San Francisco, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 4, 2025. If all options are exercised, the contract could reach $3.70 million.
Contract details
- PIID
- 75F40122C00116
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- San Francisco, CA
- First action
- August 21, 2024
- Latest action
- August 4, 2025
Description
NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO MARCH 30, 2026.
Modification timeline
-
August 4, 2025Mod P00007 · Other Administrative Action$3.59M
-
August 21, 2024Mod P00004 · Other Administrative ActionMOVE OY1 CUPS TO OY2$3.59M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40122C00116?
Contract 75F40122C00116 is a federal contract awarded to Regents Of The University Of California, San Francisco, The by Department Of Health And Human Services on August 21, 2024 for $919,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75F40122C00116?
Regents Of The University Of California, San Francisco, The won contract 75F40122C00116 from Department Of Health And Human Services.
How much is contract 75F40122C00116 worth?
Contract 75F40122C00116 has obligated $919,000 to date, with a total potential value of $3.70 million if all options are exercised.